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PENCIRIAN ASID RIBONUKLEIK BUKAN-PENGKOD-PROTEIN DI DALAM 
AGEN PATOGENIK, SALMONELLA TYPHI 
 
ABSTRAK TESIS 
 
 RNA bukan-pengkod-protein (npcRNA) merupakan satu kelas pengawalatur-ribo 
yang bertindak di dalam bentuk kompleks RNA-protein (sebagai RNPs) di dalam 
pelbagai laluan pengawalaturan. Tesis ini memberikan tumpuan ke atas pengenalpastian 
npcRNA secara eksperimental daripada bakteria patogenik Salmonella enterica serovar 
Typhi (S. Typhi), penyebab penyakit demam kepialu. Melalui pendekatan RNomics 
Eksperimental, 82 calon novel npcRNA daripada perpustakaan cDNA S. typhi telah 
dikenalpasti dan dicirikan. Daripada jumlah ini, 28 telah ditranskrip daripada IGR, 29 
ditranskrip di dalam arah antisense kepada ORF dan 18 dikenalpasti bertindihan dengan 
ORF. Sementara 7 calon yang lain telah ditranskrip daripada kawasan repititif dan 
beberapa kedudukan bukan repitatif yang lain. Sebelas npcRNA merupakan npcRNAs 
yang telahpun dilaporkan. Menariknya, 55 daripada 82 calon  yang dikenalpasti 
mempamerkan homologi kepada Escherichia coli serta belum lagi dilaporkan dari kedua-
dua organisma. Melalui analisis Pemblotan Northern, pengungkapan 28 novel npcRNA 
telah berjaya disahkan. Sejumlah 38 calon novel npcRNA adalah dikawalatur semasa fasa 
pertumbuhan, di mana 14 calon adalah dikawalatur semasa fasa pertumbuhan di dalam 
kedua-dua S. Typhi USM05 dan E. coli K12, 11 calon adalah dikawalatur semasa fasa 
pertumbuhan secara spesies-spesifik hanya di dalam S. Typhi USM05 dan 3 calon adalah 
 xvi
dikawalatur semasa fasa pertumbuhan secara spesies-spesifik hanya di dalam E. coli K12. 
Sejumlah 8 calon npcRNA adalah diungkapkan secara ubikuitus, dimana 6 calon 
diungkapkan secara ubikuitus di dalam kedua-dua S. Typhi USM05 dan E. coli K12. Dua 
calon adalah diungkapkan secara ubikuitus-spesies-spesifik hanya di dalam S. Typhi 
USM05. Tidak ada calon yang diungkapkan secara ubikuitus-spesies-spesifik di dalam E. 
coli K12. Dua daripada 38 telah ditunjukkan dikawalatur semasa fasa pertumbuhan dan 
turut diungkapkan secara ubikuitus. Ciri bagi corak pengungkapan berbeza yang telah 
diperhatikan boleh dihubungkaitkan dengan kelas npcRNA berbeza yang mana mereka 
dikumpulkan iaitu npcRNA untuk “housekeeping” dan untuk pengawalaturan. Beberapa 
calon novel npcRNA telah ditunjukkan terletak berdekatan dengan gen-gen penting yang 
kekal di dalam E. coli K12 dan di antara Salmonella. Justeru, adalah dicadangkan bahawa 
mereka mungkin adalah penting daripada segi fungsi. Secara signifikan, kajian ini telah 
menetapkan suatu pemahaman ke atas kepentingan keadaan pertumbuhan yang spesifik 
terhadap pengungkapan npcRNA. Dengan mempertimbangkan bahawa pengawalatur-
pengawalatur berkenaan mungkin diungkapkan apabila diaruhkan, molekul-molekul ini 
mungkin dapat diperkayakan dengan begitu banyak di dalam perpustakaan cDNA yang 
disediakan daripada keadaan pertumbuhan atau keadaan tekanan yang berkaitan. 
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EXPERIMENTAL RNOMICS: TOWARDS THE IDENTIFICATION AND 
CHARACTERIZATION OF NON-PROTEIN-CODING RIBONUCLEIC ACIDS 
IN PATHOGENIC AGENT, SALMONELLA TYPHI 
 
THESIS ABSTRACT 
 
 Non-protein-coding RNA (npcRNA) is a large class of riboregulators that act in 
complex with proteins (as RNPs) in diverse regulatory pathways.  This thesis focused on 
the experimental identification of small npcRNAs from Salmonella enterica serovar 
Typhi (S. Typhi), the aetiological agent of typhoid fever. By an Experimental RNomics 
approach, 82 species of uncharacterized novel npcRNA candidates were identified from 
library generated from different growth phases of a clinically isolated S. Typhi. From 
this, 28 were transcribed from the IGRs, 29 were transcribed in the antisense orientation 
of the ORFs and 18 were identified to overlap the ORFs. Another 7 candidates were 
transcribed from repetitive regions and several non-repetitive locations. Eleven known 
npcRNAs were also detected. Interestingly, 55 candidates exhibit homology to 
Escherichia coli and were not previously annotated for both organisms. By Northern Blot 
analysis, the expression of 38 novel npcRNA candidates was confirmed. A total of 28 
novel npcRNA candidates were growth phase regulated where 14 candidates were growth 
phase regulated in both S. Typhi USM05 and E. coli K12, 11 candidates were species-
specific growth phase regulated only in S. Typhi USM05 and three candidates were 
species-specific growth phase regulated only in E. coli K12. A total of 8 npcRNA 
candidates were ubiquitously expressed with 6 candidates were ubiquitously expressed in 
 xviii 
both S. Typhi USM05 and E. coli K12 and 2 candidates were species-specific 
ubiquitously expressed only in S. Typhi USM05. There was no species-specific 
ubiquitously expressed candidate observed in E. coli K12. Two out of 38 candidates were 
shown to be growth phase regulated and ubiquitously expressed. The different feature of 
expression patterns observed in this study can be associated with the different classes of 
npcRNA that they might be grouped-in, namely the housekeeping and the regulatory 
npcRNAs. A number of novel npcRNA candidates were shown to be located close to 
important genes that were conserved in E. coli K12 and among Salmonella. Thus, 
suggesting that they might be functionally important. Significantly, this study has set the 
understanding on the importance of the specific growth conditions to the expression of 
npcRNAs. The next phases of challenge are to further characterize and to elucidate the 
functions of these new classes of small RNA molecules. Considering that such regulators 
may be highly expressed upon induction, these molecules may be greatly enriched in 
cDNA libraries prepared from the relevant growth or stress condition.  
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CHAPTER 1 
INTRODUCTION 
 
(1.1) General Introduction 
It is believed that modern biochemistry arose with the first appearance of 
deoxyribonucleic acid (DNA), leading to the birth of “Central Dogma of Molecular 
Biology”. The dogma defined a general pathway for the expression of genetic 
information stored in the DNA. The genetic information is transferred into messenger-
RNA (mRNA) through transcription by RNA polymerase and is then translated on 
ribosomes, a ribonucleoprotein complex of ribosomal-RNA (rRNA), with the help of 
specialized adapter, the transfer-RNA (tRNA), that carry specific amino acid, to produce 
functional proteins. These proteins, then in turn perform all the enzymatic and structural 
functions in the cell. 
 
Consequently for decades, the belief that the critical functions of the cell and the 
complexity of an organism depend exclusively on the protein-coding genes according to 
“one gene, one protein” hypothesis (Morey and Avner, 2004) has progressively gained its 
ground and eventually created a great impact on genomic studies (e.g, genome 
sequencing project; Venter et al., 2001) in human and several selected model organisms, 
where the main interest have been put into discovering protein-coding genes (Eddy, 
2001; Morey and Avner, 2004).  
 
 2
The over-simplistic view may probably correct for the prokaryotic organisms 
where most of the earlier genetic studies have been done based on the “simple” and 
compact genome of the prokaryotes (Pang et al., 2006). However, with the discovery of 
the non-coding sequences or introns (Hastings and Krainer, 2001) that lies between 
protein-coding genes or exons, and intronic splicing activities of primary RNAs 
transcribed from eukaryotic genes, the dogma have been challenged. 
 
Furthermore, recent analysis of genomes strongly suggested that protein-coding 
genes alone are not enough to account for the complexity of higher organism (Mattick, 
2001). This can be seen from the evidences that with the increase of an organism 
complexity, the protein-coding genes contribution to its genome is tremendously 
decreased (Eddy, 2001; Szymanski and Barciszewski, 2002; Shabalina and Spiridonov, 
2004). The genomes of Caenorhabditis elegans and Drosophila melanogaster for 
example, were found to contain only twice as many protein-coding genes as in yeast and 
bacteria, and in human genome, the numbers is about twice that of the invertebrates 
(Mattick, 2001; Standish, 2002; Figure 1.1). 
 
The ribonucleic acid (RNA) molecule has been shown to be a versatile bio-
organic molecule with a variety of roles and functions in structural, genetic storage, 
regulatory and catalytic processes in living cell (Caprara and Nilsen, 2000). The 
identification of catalytic properties of the RNA subunit of ribonuclease P, aptamers, 
ribozymes, intronic self-splicing and gene silencing activities have further underlined the 
notion that the function of RNA molecules extended well beyond a transient role in 
 3
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The proportion of non-protein-coding and protein-coding sequences in several 
model organisms. The proportion of protein-coding sequences (light shaded bar) compared to 
protein-coding sequences (dark shaded bar) is increased in the genome of less complex organisms 
e.g., A. fulgidus, M. tuberculosis and E. coli. In contrast, the contribution of protein-coding 
sequences compared to the non-protein-coding sequences is decreased with the increase of the 
organism complexity as shown by fruit fly (D. melanogaster) and human (Homo sapien) where 
non-protein-coding sequences in human contributed approximately 98.5% to its genome (adapted 
from Szymanski and Barciszewski, 2002). 
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ensuring the expression of protein-coding genes (Levy and Ellington, 2001). It is 
estimated that 95% to 98.5% of the transcriptional output of eukaryotic genomes are un-
translated RNAs without protein-coding properties that are transcribed from non-coding 
sequences (Eddy, 2001; Mattick, 2001; Figure 1.1). 
 
In the literatures, the un-translated RNAs are generally referred as small RNAs 
(sRNAs) or non-coding RNAs (ncRNAs). However, the term sRNAs is predominantly 
used for the un-translated RNAs in prokaryotes (Wassarman et al., 1999; Suzuma et al., 
2002; Pichon and Felden, 2005). While the later, ncRNA is used for the un-translated 
RNAs found in eukaryotes and is originally used exclusively for polyadenylated 
eukaryotic RNAs transcribed by RNA polymerase II, carrying a 7-methylguanosine cap 
structure but lacking open reading frame (ORF). Nowadays, the term ncRNA has been 
extended to designate any piece of RNA transcripts without protein-coding capacity in 
both prokaryotic and eukaryotic cells (Eddy, 2001; Mattick and Gagen, 2001; Morey and 
Avner, 2004; Liu et al., 2006; Pang et al., 2006). 
 
 Less frequently used terms are un-translated RNAs (utRNAs), functional RNAs 
(fRNAs) and small non-coding RNAs (sncRNAs) (Ambros, 2001; Argaman et al., 2001; 
Erdmann et al., 2001b; Wagner and Flardh, 2002; Brosius, 2005; Vogel and Sharma, 
2005). Some authors have also referred them as non-messenger RNAs (nmRNAs) to 
discriminate them from mRNAs (Hüttenhofer et al., 2001). Since the majority of the 
known ncRNAs are small in size, that ranged between 20-500 nucleotide (nt), 
Hüttenhofer et al. (2001) coined and popularized the term small non-messenger RNAs 
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(snmRNAs) to refer to this group of ncRNAs. Recently, non-protein-coding RNAs 
(npcRNAs) term has also been used (Brosius and Tiedge, 2004) and the term npcRNAs is 
used in this thesis to refer to all the un-translated RNAs species.  
 
(1.2) Non-Protein-Coding RNA (npcRNA) 
The npcRNA molecules have been shown to involve in variety of functions in all 
living cells. The npcRNAs in-complexed with proteins to form ribonucleoprotein (RNP) 
complexes that functions in DNA and RNA stability. They also function in diverse 
regulatory pathways including chromosome modification, transcriptional and 
translational control, splicing, development timing control, cell differentiation, 
proliferation, apoptosis, organ development, human diseases and immune system 
(Ambros, 2001; Szymanski and Barciszewski, 2002; Cheng et al., 2003; Ranum and Day, 
2004;; Mocellin et al., 2006; O'Gorman et al., 2006; Royo et al., 2006; Barbarotto et al., 
2008; Kawaji and Hayashizaki, 2008). Their versatility has been known to be contributed 
by the chemical and physical properties of the RNA molecules (Johansson, 2005). 
 
The RNA molecules have been known to play important roles and functions well 
beyond the role of ensuring the expression of protein-coding genes (Caprara and Nilsen, 
2000; Levy and Ellington, 2001; Kawaji et al., 2008; Royo and Cavaille, 2008). Single-
stranded  RNA  molecules,  for  example,  have  been  shown to posses the ability to form  
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local secondary structures through the interactions of complementary segments within the 
same strand. These secondary structure elements can influence many cellular processes as 
mentioned earlier (Katz and Burge, 2003). 
 
The RNA molecule acquires complex folded conformations that can be applied in 
any sophisticated recognition process by providing recognition elements for protein 
binding, formation of large macromolecule complexes and catalytic reactions. The 
tertiary structure of the RNA molecules can also form a virtually unlimited number of 
highly specific ligand-binding sites that permit RNA interaction with chemically and 
structurally diverse sets of small compounds like metal ions and nucleotide (Erdmann et 
al., 2001b; Szymanski et al., 2003; Brantl, 2004; Johansson, 2005).  
 
RNA and protein bind together through recognition that occurs by induced fit 
mechanism rather than by the rigid protein-like “lock and key” docking (Moore and 
Steitz, 2002). Base pairing allows a small RNA to target other nucleic acids with a great 
specificity. They are often found to have roles that involve sequence-specific recognition 
or base complimentarity of another nucleic acid. RNA molecules by its very nature are 
ideal materials for this role. Base complimentarity allows a very small RNA to be 
exquisitely sequence specific. 
 
Many functional roles do not require the more sophisticated catalytic prowess of 
protein and could be carried out by simple RNA molecules. Post-transcriptional 
regulation, in particular, can be achieved simply by steric occlusion of sites on a target 
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pre-mRNA or mature RNA (Morey and Avner, 2004). Evolution of a small, specific 
complementary RNA can be achieved in a single step, just by a partial duplication of a 
fragment of the target gene into an appropriate context for expression of the new 
npcRNAs.  
 
Traditionally, many npcRNAs are grouped into specific classes based on their 
physical properties such as size, structure or sequence motives, protein partner or sub-
cellular location (Hüttenhofer et al., 2002). They might also be classified according to 
their functions such as catalyst, guides, catalytic cofactors, antisense RNAs, protein 
binding-site antagonists/agonist or templates (Hüttenhofer and Schattner, 2006). 
 
(1.3) Characteristic and Biogenesis of npcRNA 
Generally, npcRNAs often show only weak primary sequence conservation, lack 
of open reading frame (ORF) and are not systematically processed (Morey and Avner, 
2004). Some npcRNAs such as the 16S and 23S rRNAs in bacteria are relatively large 
from 2,000 - 4,000 nt in length. However, majority of npcRNAs are usually very small 
with size between 20 – 500 nt. The npcRNA genes are expressed in only few cells or at 
specific cell growth stages/phases (Eddy, 2002; Yuan et al., 2003). 
 
Many are expressed at low level, that other may suggest that these RNAs are 
merely transcriptional noise from illegitimate promoters. Notably, in some large size 
npcRNAs, evolutionary conservation may not be a reliable signature of functional 
npcRNAs. Unlike DNA, npcRNAs that lack of conservation does not necessarily 
 8
indicates lack of function. A number of well-studied npcRNAs, for example human’s 
XIST (17 kb) and mouse’s Air npcRNAs are poorly conserved (Oudejans et al., 2001; 
Chureau et al., 2002) but are involved in dosage compensation and X-chromosome 
inactivation during development. 
 
In eukaryotes, npcRNAs are transcribed by different polymerases. For example, 
RNA polymerase I transcribed mostly ribosomal RNAs. RNA polymerase III transcribed 
small structural RNAs like tRNAs and 5S-RNA. Whereas RNA polymerase II transcribed 
mRNAs and most other npcRNAs. Long regulatory npcRNAs in Eukaryal are believed to 
be transcribed from within a well-defined gene with polymerase II promoters and 
sometimes are alternatively spliced and/or polyadenylated (Erdmann et al., 2001a; Morey 
and Avner, 2004) and therefore might have evolved from genes that have lost their 
protein-coding capacity. Other long npcRNAs are thought to be of functional importance 
for cell viability and expressed from both chromosomes (Eddy, 2001).  
 
Some vertebrates’ npcRNAs are transcribed as monocistronic units from 
independent genes (Maxwell and Fournier, 1995). However, many npcRNAs in plant and 
yeast are processed from polycistronic precursors (Maxwell and Fournier, 1995; 
Samarsky and Fournier, 1999). There are some of the eukaryotes’ npcRNAs that are not 
independently transcribed at all but they are processed out of the introns of host 
transcripts (Eddy, 2002) or may be produced from intergenic transcription (Morey and 
Avner, 2004). Some host genes are non-protein coding and appeared to act exclusively as 
vehicles for npcRNAs only (Tycowski et al., 1996; Bortolin and Kiss, 1998; Pelczar and 
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Filipowicz, 1998). There are also npcRNAs that are generated from complex 
transcription unit of spanning tandem repetitions of the intron and non-protein coding 
flanking exons (Cavaille et al., 2000). The transcriptions of npcRNAs in eukaryotes are 
illustrated in Figure 1.2:A. 
 
Bacterial npcRNAs are mostly detected from the short intergenic region of the 
genomes and probably derived from unidirectional, convergent or divergent orientation 
of the ORFs (Rogozin et al., 2002). The transcriptions of npcRNAs in prokaryotes are 
illustrated in Figure 1.2:B. Most antisense npcRNAs appeared to overlap the 3’-ends un-
translated region (UTR) of the protein-encoding ORF, whereby the translation 
termination codon of the ORF falls in the 5’-end or 3’-end half of the npcRNA (Dahary et 
al., 2005). The base-pairing regulatory RNAs or riboregulators (antisense RNAs) usually 
found in bacteria exert their functions via blocking translation by sequestration of 
ribosome loading site, promote target RNA decay by creating RNase III substrates, 
induce premature termination of transcription, interfere with activator pseudoknots or 
even activate an mRNA by unfolding a ribosome-binding site (Wagner and Flardh, 
2002). Majority of antisense npcRNAs in bacteria are trans-encoded in the chromosome. 
 
The antisense RNAs can be separated into cis-encoded and trans-encoded groups. 
The cis-encoded group consisted of npcRNAs are encoded at the same genetic location 
but  on the  opposite  strand  to  the RNA they act upon, thus  exhibits a long perfect 
base-pairing  with  their  potential  target.  The  trans-encoded  group on the other hand is  
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Figure 1.2: The organization of npcRNA genes. (A) npcRNA genes organization in 
eukaryote. In eukaryotes, npcRNAs can be transcribed either from (i) monocistronic units of 
independent protein-coding genes, (ii) polycistronic precursors of protein-coding genes cluster or 
intergenic region of the introns of host transcripts that are maybe (iii) single intronic region or (iv) 
long expanding intronic cluster. There are npcRNAs that are generated from (v) complex 
transcription unit of spanning tandem repetitions of the intron and protein-coding flanking exons. 
Some host genes are non-protein-coding genes and appeared to act exclusively as vehicles for 
npcRNAs only; they are similarly organized as in (i) and (ii), however the genes are non-protein-
coding genes. (B) npcRNA genes organization in prokaryote. In prokaryote, the npcRNAs can 
be derived from unidirectional, convergent or divergent to the ORF’s orientation (i.e, npcRNA1, 
npcRNA2, npcRNA3 and npcRNA4 are unidirectionally transcribed to GeneA, GeneB and 
GeneC, respectively; npcRNA5 and npcRNA6 are convergently transcribed to GeneA and 
GeneB, respectively; npcRNA5 and npcRNA6 are divergently transcribed to GeneB and GeneC, 
respectively). Bacterial npcNAs are mostly detected from the short intergenic spacer region of the 
genomes i.e, npcRNA2 and npcRNA5. The cis-antisense npcRNAs (i.e, npcRNA1) are 
transcribed from the opposite strand of the ORFs (i.e, GeneA). The trans-antisense npcRNAs (i.e, 
npcRNA1) may be transcribed from the same or opposite strand (i.e, npcRNA6) at a distance 
away from the ORFs (the red arrows indicated the target gene). Some npcRNAs can also be 
found to overlap the 3’ end or 5’ end of the ORFs where large sequences of the npcRNAs were in 
the intergenic region (i.e, npcRNA3, npcRNA4, npcRNA6 and npcRNA7). NpcRNA: non-
protein-coding RNA (adapted from Hüttenhofer et al., 2004). 
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consisted of npcRNAs that are encoded at a chromosomal location distinct from the RNA 
target they act upon and generally do not exhibit perfect base-pairing with their potential 
target (Figure 1.2:B) (Storz et al., 2005). 
 
Interestingly, there are significantly large numbers of bacterial trans-encoded 
antisense npcRNAs such as MicC, MicF and DsrA, that show strong requirement for the 
RNA chaperone protein complex; an Sm and Sm-like homolog regulator in the 
eukaryotes; known as host factor 1 (Hfq) (Moll et al., 2003; Storz et al., 2005; Vecerek et 
al, 2008). Most of these npcRNAs share a similar structure composed of three stem-loops 
(Sauter et al., 2003; Zhang et al., 2003). The 11.2 kD Hfq protein forms a homo-
hexameric ring-shaped structure that bind to AU-rich sequences in npcRNAs (Wagner 
and Flardh, 2002; Moll et al., 2003; Storz et al., 2005). Hfq binding can either promotes 
npcRNA-mRNA base-pairing, npcRNA/mRNA accessibility to RNases or protecting 
npcRNA/mRNA against Rnase-E via structural change in the npcRNA or mRNA 
(reviewed by Storz et al., 2005). The overview and model for the Hfq-mediated 
DsrA/RpoS regulation in E. coli is illustrated in Figure 1.3. 
 
(1.4) Known Function of npcRNAs 
Most npcRNAs are regulatory molecules that seemed to fine-tune cellular 
responses to environmental changes by integrating environmental signals into global 
regulation. They are involved in many important cellular processes such as post-
transcriptional gene silencing, RNA editing, pre-mRNA splicing, protein stability, 
nucleotide  modification  of  RNA,  mRNA stability and translation and growth phases or  
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Figure 1.3: Overview and model of DsrA/Hfq/rpoS-mediated regulation. In this model, The 
hexagonal ring, Hfq complex unfolds the rpoS 5’-leader at the RBS region, allowing DsrA 
Domain I to form base-pairing formation with the rpoS mRNA. This stabilizes an alternative 
conformer of rpoS mRNA that leads to increase translation of RpoS by exposing the RBS. SD: 
Sine-Delgarno sequence, RBS: ribosomal binding site, Hfq: host factor 1 protein, 5’: 5’ end, 3’: 
3’ end, Start: Start codon (adapted from Brescia et al., 2003). 
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developmental regulation (Eddy, 2001; Suzuma et al., 2002; Altuvia, 2004) through 
several mechanisms such as RNA-RNA or RNA-DNA base-pairing, RNA-protein 
interactions and intrinsic RNA activity (Altuvia and Wagner, 2000; Wassarman and 
Storz, 2000). The npcRNAs are also found to involve in other cellular processes such as 
DNA transcription, chromosome replication, RNA processing, protein synthesis and 
protein translocation. Some of the known functions of the npcRNAs in prokaryote and 
eukaryote are briefly described below. 
 
(1.4.1) npcRNA Functions in Post-Transcriptional Gene Silencing 
A class of small npcRNAs termed as micro RNAs (miRNAs) and short interfering 
RNAs (= small interfering RNAs; siRNAs) are found to involve in post-transcriptional 
gene silencing in eukaryotes. Both miRNAs and siRNAs are generated from long, 
double-stranded RNAs by a protein complex containing an RNase III-type endonuclease 
called Dicer (Grishok et al., 2001; Hutvagner et al., 2001; Ketting et al., 2001, Storz et 
al., 2005; Kawaji and Hayashizaki, 2008).  
 
Dicer cleaves double stranded RNA templates into short siRNAs of 21 to 23 nt 
that in turn, are able to target certain mRNA regions complementary to the siRNAs 
resulting in specific cleavage of the mRNA at this site and in loss of function of this 
mRNA (Bass, 2000; Zamore et al., 2000; Elbashir et al., 2001; Ketting et al., 2001; 
Nykanen et al., 2001; Zamore, 2001). This mechanism of mRNA degradation has been 
termed  RNA interference (RNAi)  (Fire et al., 1998)  and is thought to have evolved as a  
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mechanism for antiviral defense by targeting certain double stranded RNA viruses 
(Hamilton and Baulcombe, 1999; Tabara et al., 1999; Ketting et al., 1999; Sharp and 
Zamore, 2000; Wu-Scharf et al., 2000; Elbashir et al., 2001; Waterhouse et al., 2001). 
 
In miRNAs, the RNA precursors are stable stem-loop structures of 60 – 70 nt in 
length. The 22 nt miRNAs are processed from the stem portion of the precursor 
(Hutvagner et al., 2001; Grishok et al., 2001) and only one of the strands of the RNA 
helix is processed and stable. The lin-4 (22 nt) and let-7 (23 nt) are two examples of 
miRNAs found in C. elegans. The common denominator between miRNAs and siRNAs 
is their size (21 – 23 nt) as well as a similar mechanism of generation i.e. from a larger 
RNA precursor. The generation and mechanism of action of siRNA and miRNA is 
illustrated in Figure 1.4. 
 
However, it is unclear whether the siRNA-endonuclease complex contains double 
stranded siRNA. The second difference between miRNAs and siRNAs is their function. 
While siRNAs are able to degrade specific mRNAs by the RNAi mechanism, miRNA 
presumably do not degrade their target mRNAs, but apparently exert their function at the 
level of translation regulation by binding to the 3‘-UTRs of mRNAs. 
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Figure 1.4: Mechanisms of action for siRNA and miRNA. The 21–23 nt long siRNAs or 
miRNAs are processed from long, bimolecular or intramolecular RNA duplexes by Dicer and 
ATP; for miRNAs, only one strand appears to be stable while for siRNAs both strands can be 
detected at this stage; subsequently, miRNAs and siRNAs assemble into RISCs (requiring ATP), 
that contain a single stranded RNA molecule and target mRNAs either in their ORFs or 3‘-UTRs. 
For miRNAs this leads to translational arrest, while for siRNAs this results in cleavage of the 
mRNA target at the site of complementarity. As opposed to animal miRNAs, the majority of 
plant miRNAs have been proposed to function similar to siRNAs, namely degradation of 
mRNAs. ATP: adenosine triphosphate, miRNA: micro RNA, siRNA: short interference RNA, 
RISC: RNA-induced silencing complex, ORF: open reading frame, UTR: untranslated region 
(adapted from Rhoades et al., 2002) 
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 (1.4.2) npcRNA Functions in RNA Editing 
RNA editing is a co-transcriptional or post-transcriptional process by which a 
genome-encoded RNA sequence is altered by nucleotide insertions, deletions or base 
modifications (Figure 1.5). In the mitochondria of trypanosomatid protozoa, the 
precursors of messenger RNAs (pre-mRNAs) are edited by site-specific insertions and 
deletions of uridylate (U) residues. Small trans-acting, guide RNAs (gRNAs) supplied 
the genetic information for this RNA editing process. U-insertion editing occurs through 
a series of enzymatic steps that begins with gRNA-directed, pre-mRNA cleavage. 
Inserted U residues are derived from free uridine triphosphate and are added to the 3' 
terminus of a 5' pre-mRNA cleavage product (Kable et al., 1997; Simpson et al., 2000). 
 
(1.4.3) npcRNA Functions in Pre-mRNA Splicing 
In Eukarya, small nuclear RNAs (snRNAs) play a central role in the splicing of 
pre-mRNAs (Will and Luhrmann, 2001). Eukaryal genes are often interrupted by introns 
in primary transcripts. The mature RNAs are obtained after the introns are removed. In 
this process, several small nuclear RNAs (snRNA U1, U2, U4, U5 and U6) are involved. 
Together with their specific protein components, small nuclear ribonucleoprotein 
(snRNP), they are required for the assembly of a ribonucleoprotein complex termed the 
eight spliceosome. The spliceosome catalyzes splicing of pre-mRNAs by removing non-
coding introns from eukaryal mRNA precursors (Moore and Sharp, 1993) (Figure 1.6). 
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Figure 1.5: Mechanism of U insertion/deletion RNA editing. The vertical lines indicate base 
pairs. The arrowheads indicate sites of cleavage. Modified enzyme cascade model. The 3´-oligo 
(U) tail of the gRNA (guide-RNA) is shown as a single-stranded overhang, but it is possible that 
the tail can interact with the purine-rich pre-edited sequence and the gRNA may have secondary 
structure. In the U deletion model 3 unpaired Us (in gray) to be deleted are shown as an example. 
It is possible that the U addition activity adds U’s to the 3´-end of the cleavage fragment at the 
deletion site, which are then trimmed back, but this scenario is not indicated. In the U addition 
model 13 U’s are shown added to the 5´-fragment, but the evidence indicates that the number of 
added Us is actually heterogeneous. In the ‘guided’ diagrams the exonuclease nucleotide 
trimming is complete, yielding the correct –3 or +3 guided products. If trimming is incomplete or 
excessive prior to ligation, gRNA-dependent misedited products are produced, as shown in the 
‘misedited’ diagram (adapted from Simpson and Emeson, 1996). 
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Figure 1.6: Spliceosome assembly. As the newly transcribed mRNA is emerging from the RNA 
polymerase II, U1 and U2 snRNPs bind through RNA:RNA base pairing to the 5´ splice and 
branch sites, respectively. U2 snRNA binding is assisted by the U2AF, which interacts with the 
polypyrimidine tract and the 3´splice site. U5 snRNP enters as a part of the tri-snRNP complex 
with U4 and U6 snRNAs and base-pairs with the last two nucleotides of exon 1 and the first two 
nucleotides of exon 2. This brings together the two phosphodiester bonds that must be broken and 
reformed during splicing reaction. Acting like a chaperone, U4 initially base-pairs extensively 
with U6. This interaction is then disrupted so that U6 can interact with U2 near the activated 
adenosine branch
 
point (bp). As U5 and U6 form these interactions with the pre-mRNA, U1 
leaves, allowing U6 access to the 5´ splice site. Through this trans-esterification reaction, the 
phoshodiester bond at the 5´ splice site is broken, and eventually exon 1 is joined to exon 2, 
resulting in the mature mRNA product and the lariat intron (adapted from 
http://www.designeduniverse.com/articles/Nobel_Prize/spliceosome_cycle.jpg, 2005). 
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(1.4.4) npcRNA Functions in Protein Stability 
Another unique bacterial npcRNA termed transfer-messenger RNAs (tmRNAs) 
have been shown to affect protein stability. The ssrA RNA and 10Sa RNA are example of 
tmRNAs. They varied in size between 95 nt in S. Typhimurium LT2 to 466 nt in E. coli 
K12. The tmRNA is recognized as both tRNA and mRNA by stalled ribosomes (Gillet 
and Felden, 2001). When a ribosome is stalled, tmRNA is delivered to the site of the 
stalled ribosome and the nascent polypeptide is then transferred to the alanine-charged 
tRNA portion of tmRNA. The transcript is then placed by the mRNA portion of tmRNA, 
which encodes a tag for degradation of the stalled peptide. The mechanism and function 
of tmRNA is illustrated in Figure 1.7. 
 
(1.4.5) npcRNA Functions in Nucleotide Modification of RNA 
The biogenesis of eukaryal ribosomes in the nucleolus involves the processing of 
the rRNA primary transcript. Extended spacer regions from precursor rRNA are removed 
and mature ribosomal RNAs are generated. Before its cleavage by endonucleases and 
exonucleases, the nascent rRNA undergoes a pattern of nucleoside modifications. The 
two prevalent types of modification are 2‘-O-ribose methylation or pseudouridylation. 
Each of these modifications is found at about 50 to 100 sites per eukaryal ribosome in 
contrast to the E. coli ribosome, which contains only four ribose-methylated nucleotides 
and 10 pseudouridines (Maden, 1990; Cavaille and Bachellerie, 1998). 
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Figure 1.7: Mechanism and function of tmRNA. A tmRNA is delivered to the site of a stalled 
ribosome and the nascent polypeptide (green boxes) is then transferred to the alanine-charged 
(yellow box) tRNA portion of tmRNA. The transcript is then placed by the mRNA portion of 
tmRNA, which encodes a tag (red boxes) for degradation of the stalled peptide (adapted from 
http://www.indiana.edu/~tmrna/images/model.gif). 
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Both types of modification are directed by small nucleolar ribonucleoprotein 
particles (snoRNPs), each composed a small nucleolar RNA (snoRNA) and a set of 
proteins (Maxwell and Fournier, 1995; Smith and Steitz, 1997; Weinstein and Steitz, 
1999). The specificity of modification is achieved by base pairing of snoRNA with pre-
rRNA across the site to be modified. The snoRNAs are also involved in nucleotide 
modification in spliceosomal snRNAs in vertebrates (Tycowski et al., 1996; Hüttenhofer 
et al., 2001), tRNAs in Archaea and probably in eucaryotic mRNAs as well (Cavaille et 
al., 2000). 
 
The snoRNAs can be grouped into two major classes based on their structure and 
conserved sequence motifs (Balakin et al., 1996). The C/D box family which guides 2’-
O-ribose methylation and the H/ACA box family which guides pseudouridylation 
(Tollervey and Kiss, 1997; Smith and Steitz, 1997; Bachellerie et al., 2002) snoRNA 
represent the most well studied npcRNAs. The structural feature of C/D and H/ACA box 
snoRNAs is illustrated in Figure 1.8 and Figure 1.9. 
 
(1.4.6) npcRNA Functions in mRNA Stability and Translation 
In bacteria, npcRNAs can also be involved in regulation of translation by base-
pairing upstream of the initiator AUG start codon where they either block translation or 
compete with an inhibitory cis-acting secondary structure to open up the translation 
initiation site (Wassarman et al., 1999; Wagner et al., 2002). In E. coli, examples of these 
npcRNAs are OxyS RNA, DsrA RNA, and MicF RNAs. The mechanisms of action of 
these npcRNAs are briefly illustrated in Figure 1.10. 
 22
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.8: Structural features of C/D box snoRNAs. (A) Schematic secondary structure of the 
eukaryotic C/D box snoRNAs. Conserved motifs are boxed and sequence tracts complementary 
to the cognate RNA target (antisense elements) are depicited by thick blue lines. (B) Canonical 
structure of the C/D guide RNA duplex. Indicated is the region of complementarity to target 
rRNA that is positioned 5' to the D or D' box; 2'-O-ribose methylation is directed to the 
nucleotide in the rRNA that participates in a Watson–Crick base pair five nucleotides upstream of 
the D' or D box. (C) Example of evolutionary conserved essential core proteins (adapted from 
Hüttenhofer et al., 2004). 
 
 
 23
 
 
 
 
 
 
 
 
 
 
Fig. 1.9: Structural features of H/ACA box snoRNAs. (A) Schematic secondary structure of 
eukaryotic box H/ACA snoRNAs. Conserved motifs are boxed and sequence tracts 
complementary to the cognate RNA target (antisense elements) are depicited by thick blue lines. 
(B) Canonical structure of the H/ACA guide RNA duplex. Indicated is the region containing one 
or two sequence tracts complementary to rRNA that are located within the bulge region of the 5' 
or 3' helices; base pairing to rRNA positions the uridine nucleotide to be modified in the 
pseudouridylation pocket between the regions of rRNA-snoRNA complementarity. The target 
uridine is located 14 to 16 nt upstream from the ACA or H box. N: any nucleotide. (C) Example 
of evolutionary conserved essential core proteins (adapted from Hüttenhofer et al., 2004). 
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Fig. 1.10: Mechanism of translational inhibition/activation in E. coli directed by npcRNAs. 
(A) npcRNA binds to Shine-Dalgarno sequence and/or initiation codon, thereby inhibiting 
translation of the ORF. (B) npcRNA disrupts the double-strand RNA structures between 5’-UTR 
and SD thus allowing translation to occur. SD: Shine-Dalgarno sequence, ATG: initiation codon, 
ORF: Open reading frame, 5’-UTR: 5’-untranslated region, 3’-UTR: 3’-untranslated region 
(adapted from Tang et al., 2002). 
 
 
 
